SBIR/STTR Research Award
IMPROVED DNA POLYMERASES FOR GENOMIC SEQUENCING
Award amount
$99,510Program and phase
SBIR · Phase IAward year
2002Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LUCIGEN CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- L9SNJEY728V3
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): This technology is intended to reduce the costs of sequencing by improving the ability to sequence through difficult templates such as G/C or A/T rich regions, direct and inverted repeats, homopolymer tracts, and di, and tri-nucleotide repeats. This will decrease finishing costs by reducing gaps. Additional improvements will enable direct sequencing of colony derived plasmids and more robust sequencing of BACs, cosmids and genomic DNA. These objectives will be attained by examining an entirely new class of DNA polymerases as improved sequencing reagents.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Tools for Exceptional Overexpression and Structural Stabilization of Membrane Proteins in Mammalian Cells
- Rapid and Simple Device for Point-of-Care Molecular Detection of Arboviruses
- A Microfluidic System for POC Molecular Diagnosis of HPV in Oral Fluids
- Mini Chromosome and Fluorescent Proteins for Expression of Protein Complexes
- Integrated biochemical and bioinformatic technologies for accurate transcriptome-wide full-length RNA assembly.
Research funding history
51 SBIR/STTR records share this UEI (2000–2016). Reported award amounts total $23,195,889. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, Department of Agriculture, Department of Energy